Novartis Profile Banner
Novartis Profile
Novartis

@Novartis

300,106
Followers
528
Following
1,799
Media
13,064
Statuses

An innovative medicines company working to reimagine medicine. See our community guidelines:

Basel, Switzerland
Joined November 2008
Don't wanna be here? Send us removal request.
@Novartis
Novartis
3 days
We are investing in every aspect of #RadioligandTherapy (RLT) to deliver to patients. With a global footprint, industry-leading supply chain and clear vision for this treatment paradigm, we are committed to the present—and future—of RLTs. #ReimagineMedicine
0
3
13
@Novartis
Novartis
8 days
We are where we are today because people believed things were possible. Like eliminating a disease. We need to come together as the global #malaria community to finally outsmart the mosquito #WorldMalariaDay
1
4
10
@Novartis
Novartis
9 days
For #Investors : CEO @VasNarasimhan joined @carlquintanilla on @moneymoverscnbc to discuss strong Q1 #Earnings , driven from: ➡️ Product portfolio, new launches and growth drivers ➡️ Confidence in innovative medicines ➡️ Continued pipeline momentum $NVS $NOVN #NVSQ124
@moneymoverscnbc
Money Movers
10 days
"We're making the right adjustments to our pipeline and portfolio to enable us to bring a whole new wave of medicines forward." After delivering an earnings beat in Q1, @Novartis CEO @VasNarasimhan discusses how the pharmaceutical giant is navigating the Inflation Reduction Act.
1
3
0
2
5
15
@Novartis
Novartis
10 days
CEO @VasNarasimhan discusses strong Q1 #Earnings on @BloombergTV : ➡️ Confidence in outlook. Raises FY guidance ➡️ Performance in key brands across US, Europe, Japan & China ➡️ Scaling innovative medicines, incl. for cancer using advanced therapies $NVS $NOVN #NVSQ124 #investors
1
1
8
@Novartis
Novartis
10 days
For #Investors : Novartis is prioritizing an emerging technology platform called #RadioligandTherapy (RLT), with continued investment into new R&D capabilities and manufacturing scale. $NVS $NOVN #NVSQ124
1
5
9
@Novartis
Novartis
10 days
Q1 Earnings: A strong start to the year with continued momentum in our business and pipeline. Performance across all key growth brands and geographies gives continued confidence in our mid- and long-term growth. Guidance raised for full year 2024. $NVS $NOVN #NVSQ124
1
7
15
@Novartis
Novartis
10 days
#NVSQ124 Novartis tweets on Q1 2024 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: $NVS $NOVN
0
0
6
@Novartis
Novartis
11 days
Novartis will issue Q1 2024 results on Tuesday, Apr 23. We invite #investors to our #earnings webcast to hear updates on our growth and performance. $NVS $NOVN #NVSQ124
0
0
11
@Novartis
Novartis
18 days
Every step of our #RadioligandTherapy (RLT) manufacturing process reflects our deep commitment to deliver these treatments to patients at the speed they need them. #ReimagineMedicine
5
1
9
Novartis Retweeted
@NovartisUS
Novartis US
29 days
Today, Indiana state officials, and professional and patient groups joined us for an opening ceremony event to celebrate our new #radioligandtherapy manufacturing facility in Indianapolis. RLT is changing the way cancer is treated, and Novartis is proud to lead the way.
Tweet media one
1
4
20
@Novartis
Novartis
2 months
Our CEO @VasNarasimhan discusses business with David Rubenstein on @BloombergTV , including: ➡️ The impact of AI on drug R&D ➡️ How recent acquisitions bolster our pipeline ➡️ New growth areas and innovations in medicine Watch here: $NVS #Investors
@BloombergTV
Bloomberg TV
2 months
Novartis CEO Vas Narasimhan discusses why the pharmaceutical industry is a good investment. Watch this episode of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
1
1
2
5
3
23
@Novartis
Novartis
3 months
In 2023, we reached over 280 million people with our medicines. Entering our new era as an innovative medicines company, we work every day to restore possibilities for the millions of people living with major diseases. $NVS #NVSFY23
19
17
132
@Novartis
Novartis
3 months
#NVSFY23 Novartis tweets on Full Year and Q4 2023 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information . $NVS $NOVN
2
1
16
@Novartis
Novartis
3 months
Novartis will issue Full Year and Q4 2023 results on Wednesday, Jan 31. We invite #investors to our #earnings conference call to hear updates on our performance and strategy as a pure-play innovative medicines company. $NVS $NOVN #NVSFY23
5
4
40
@Novartis
Novartis
6 months
More than 2 million people are diagnosed with #LungCancer yearly, and each one has their own unique cancer journey. At Novartis, we are committed to improve patient outcomes through innovative medicines. Learn more this #LCAM :
19
31
284
@Novartis
Novartis
6 months
In drug development, confidence in your science makes it possible to choose bold approaches. Read how an unexpected approach to clinical studies showed how thinking big when the science is right can make all the difference.
7
11
27
@Novartis
Novartis
6 months
The stigma surrounding #lungcancer is a real barrier to improving screening conditions and helping patients get the help they need. A focus on spreading awareness and encouraging education can help break down the attitudes toward lung cancer.
@LCAM_org
LCAM Coalition
6 months
People often say this phrase to combat the stigma that this is a “smoker’s disease.” Anyone can get lung cancer—and everyone should be treated with empathy and ❤️. Get the facts this #lungcancerawarenessmonth . #lungcancer #lcam
Tweet media one
0
1
9
3
13
14
@Novartis
Novartis
6 months
#Prostatecancer is a complex disease. At Novartis, we are committed to supporting education and awareness around prostate cancer to help those living with its realities feel empowered to take action for the care they want and deserve. #Movember
1
9
16